Physician profile
Taylor Wright Mclendon
NPI 1144502436
$3,850.88
in general payments reported to CMS, 2019-2025
14 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $586 · 2021: $801 · 2022: $634 · 2023: $601 · 2024: $598 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,331.65 | 2023-2025 | |
| Allergan, INC. | $1,046.43 | 2020-2022 | |
| Tela Bio, INC. | $320.25 | 2020-2022 | |
| Axogen | $311.16 | 2020-2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Tepha INC | $182.52 | 2019-2020 | |
| Stryker Corporation | $148.15 | 2020 | |
| Baxter Healthcare | $132.16 | 2023 | Tisseel |
| Davol INC. | $120.72 | 2024-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $71.58 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $60.35 | 2021-2023 | |
| Mentor Worldwide LLC | $44.77 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $34.00 | 2024 | Dysport |
| Sientra, INC. | $30.98 | 2022 | |
| Viz.Ai, INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Mclendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.